Related Experiment Video
Updated: Dec 5, 2025
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
659
Erectile Dysfunction in Men With Psoriatic Arthritis: A Population-based Cohort Study.
Katelynn M Wilton1, Sara J Achenbach2, Paras Karmacharya3
1K.M. Wilton, BS, Medical Scientist Training Program, Mayo Clinic College of Medicine and Science.
The Journal of Rheumatology
|October 16, 2020
Summary
Men with psoriatic arthritis (PsA) may face a higher risk of erectile dysfunction (ED). Further research is needed to confirm this association and explore potential underlying causes in this patient group.
Area of Science:
- Rheumatology
- Urology
- Epidemiology
Background:
- Psoriatic arthritis (PsA) is a chronic inflammatory disease.
- Erectile dysfunction (ED) is a common condition with multifactorial causes.
- The relationship between PsA and ED requires further investigation.
Purpose of the Study:
- To determine the incidence of erectile dysfunction (ED) in a population-based cohort of men diagnosed with psoriatic arthritis (PsA).
Main Methods:
- A population-based cohort study compared men with PsA to an age-matched control group.
- Demographic data, ED status, and confounding diagnoses were extracted from medical records.
- Cumulative incidence of ED was analyzed, adjusted for mortality risk.
Main Results:
- The study included 128 age-matched pairs. Pre-diagnosis ED prevalence was 7% in PsA patients versus 3% in controls (P=0.16).
- Post-diagnosis, PsA was associated with a non-significant increased risk of ED (HR 1.45).
- No significant differences in confounding factors or ED treatments were observed between groups.
Conclusions:
- Men with PsA may have an elevated risk of ED, though this study was likely underpowered to detect statistical significance.
- Further research is necessary to ascertain if traditional ED risk factors are more prevalent in men with PsA.
More Related Videos
Related Concept Videos
01:20Disorders of the Male Reproductive System
3.8K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.8K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
283
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
283
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
101
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
101
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
209
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
209
01:11Genome-wide Association Studies-GWAS
15.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.0K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
369
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
369